Journal Information
Vol. 14. Issue 4.
Pages 327 (July - August 2010)
Share
Share
Download PDF
More article options
Vol. 14. Issue 4.
Pages 327 (July - August 2010)
Letter to editor
Open Access
Overwhelming diffuse psoriasis during chronic HCV infection, after peginterferon-ribavirin treatment, supported by frequent resort to filgrastim rescue
Visits
2971
Sergio Sabbatani, Roberto Manfredi
Corresponding author
roberto.manfredi@unibo.it

Correspondence to: Associate Professor of Infectious Diseases, University of Bologna c/o Infectious Diseases, S. Orsola Hospital Via Massarenti 11 – Bologna, Italy I-40138. Tel.: +39-051-6363355; fax: +39-051-343500.
Department of Clinical and Experimental Medicine, Division of Infectious Diseases, “Alma Mater Studiorum” University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
This item has received

Under a Creative Commons license
Article information
Full text is only aviable in PDF
References
[1.]
M. Simin, J. Brok, D. Stimac, C. Gluud, L.L. Gluud.
Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C.
Aliment Pharmacol Ther, 25 (2007), pp. 1153-1162
[2.]
T. Yamamoto, H. Yokozeki, K. Nishioka.
Evaluation of psoriatic patients with HCV infection.
J Dermatol, 32 (2005), pp. 769-770
[3.]
S. Imafuku, A. Tashiro, M. Furue.
Ciclosporin treatment of psoriasis in a patient with chronic hepatitis C.
Br J Dermatol, 156 (2007), pp. 1367-1369
[4.]
G. Linardaki, O. Katsarou, P. Ioannidou, A. Rarafoulidou, K. Boki.
Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.
J Rheumatol, 34 (2007), pp. 1353-1355
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools